Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 03, 2013
The new Secura laboratory balance developed by Sartorius for applications in regulated areas such as pharmaceutical labs fulfills particularly high reliability requirements. The balance monitors its ambient conditions automatically, thereby ...
read more
Wednesday, December 16, 2020
Mesquite, TX MPM Medical is voluntarily recalling one lot of Regenecare HA Hydrogel to the consumer level.
read more
MS Pharma has entered into an agreement to acquire 100% of the outstanding shares in Genepharm, a European pharmaceutical company.
read more
Wednesday, December 01, 2021
Molecular Targeting Technologies, Inc. (MTTI) and Evergreen Theragnostics, Inc., announced an agreement in which Evergreen will manufacture MTTI's EvaThera™ platform of radiopharmaceuticals.
read more
Tuesday, December 01, 2020
Mustang Bio and Minaris have signed an agreement to enable technology transfer and GMP clinical manufacturing of Mustang’s MB-107 lentiviral gene therapy program for the treatment of XSCID in Europe.
read more
Mylan has restarted production of hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility.
read more
Tuesday, September 08, 2020
Mylan announced an agreement to acquire the related intellectual property and commercialization rights of Aspen's thrombosis business in Europe.
read more
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
read more
Monday, December 04, 2017
Mylan and Aspen announced the U.S. launch of Myleran Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version of Busulfex Injection.
read more
nanoComposix recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public Health.
read more
Wednesday, March 14, 2018
Nanologica AB has entered into a service agreement with global CDMO Sterling Pharma Solutions for the large-scale production of silica particles.
read more
Tuesday, September 14, 2021
Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of viral vaccines BSL2/BSL3, oncolytic viruses and viral vectors, announces the next phase in its partnership with FluGen, Inc., a clinical-stage vaccine company ...
read more
Monday, September 25, 2017
Jaguar Health announced its wholly-owned subsidiary, Napo Pharmaceuticals, has entered into a Termination, Asset Transfer and Transition Agreement with India-based Glenmark Pharmaceuticals.
read more
Monday, February 25, 2019
Nemus Bioscience has signed an agreement with Pharmaceuticals International Inc. (Pii), a CDMO to develop a sterile eye drop dosage formulation of NB1111 for human dosing.
read more
Friday, September 14, 2018
Nephron Pharmaceuticals is currently producing medications at its West Columbia, S.C. facility while monitoring the effects of Hurricane Florence.
read more